Study Suggests Glucosamine Linked to Faster Alzheimer's Progression
A recent major study indicates a potential connection between the popular joint supplement glucosamine and an accelerated progression from mild cognitive impairment (MCI) to Alzheimer's disease. Researchers identified a 25% increased likelihood of developing dementia among individuals who use glucosamine. The study also uncovered biological factors that may provide insight into this observed association.
A significant study has put forth the suggestion that glucosamine, a widely used supplement for joint pain, may be associated with a more rapid advancement from mild cognitive impairment (MCI) to Alzheimer's disease.
The research indicates that individuals who use glucosamine showed a 25% higher probability of developing dementia. This finding is a key outcome of the study, which investigated the potential impacts of the supplement on cognitive health.
In addition to the statistical link, the study's researchers also identified specific biological clues. These clues may offer explanations for the observed relationship between glucosamine use and the accelerated progression of cognitive decline.
According to Science Daily, these findings highlight a potential area for further investigation into the broader implications of glucosamine supplementation.
Advertisement
AdSense slot • inline
